Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.

Autor: Barbui T; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. tbarbui@fondazionefrom.it., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico 'A. Gemelli' IRCCS, Rome, Italy., Alvarez-Larran A; Hospital Clinic de Barcelona, Barcelona, Spain., Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Masciulli A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Carobbio A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Ghirardi A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Ferrari A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy., Cancelli V; Spedali Civili, Brescia, Italy., Elli EM; Hematology Division and Bone Marrow Transplant, San Gerardo Hospital, ASST Monza, Monza, Italy., Andrade-Campos MM; Hospital del Mar - IMIM, Barcelona, Spain., Kabat MG; Hospital Universitario la Paz, Madrid, Spain., Kiladjian JJ; Hospital Saint-Louis, Paris, France., Palandri F; Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italia., Benevolo G; AOU Città della Salute e della Scienza di Torino, Torino, Italy., Garcia-Gutierrez V; Hospital Ramon y Cajal, IRYCIS, Madrid, Spain., Fox ML; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, 115-117, 08035, Barcelona, Spain., Foncillas MA; Hospital Universitario Infanta Leonor, Madrid, Spain., Morcillo CM; Hospital General Universitario de Albacete, Albacete, Spain., Rumi E; Department of molecular medicine, University of Pavia, Pavia, Italy., Osorio S; Hospital Gregorio Maranon, Madrid, Spain., Papadopoulos P; Hospital Clinico San Carlos, Madrid, Spain., Bonifacio M; Ospedale Policlinico 'G.B. Rossi', Borgo Roma, Verona, Italy., Cervantes KSQ; Hospital Universitario de Mostoles, Madrid, Spain., Serrano MS; ICO L'Hospitalet-Hospital Moises Broggi, Sant Joan Despì, Barcelona, Spain., Carreno-Tarragona G; Hospital Universitario 12 de Octubre, Madrid, Spain., Sobas MA; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wrocław, Poland., Lunghi F; IRCCS Ospedale San Raffaele, Milano, Italy., Patriarca A; AOU Maggiore della Carità, Novara, Italy., Elorza BN; Hospital Moncloa, Madrid, Spain., Angona A; ICO Girona Hospital Josep Trueta, Girona, Spain., Mazo EM; Hospital Universitario Principe de Asturias, Alcalà de Henares, Madrid, Spain., Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Carli G; Ospedale San Bortolo, Vicenza, Italy., Cuevas B; Hospital Universitario de Burgos, Burgos, Spain., Hernandez-Boluda JC; Hospital Clinico Universitario, INCLIVA, Valencia, Spain., Abadia EL; Hospital General de Elche, Elche, Alicante, Spain., Cirici BX; Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Joseo Carreras Leukemia Research Institute, Badalona (Barcelona) Spain, Universitat Autònoma de Barcelona, Barcelona, Spain., Guglielmelli P; Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Garrote M; Hospital Clinic de Barcelona, Barcelona, Spain., Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Daffini R; Spedali Civili, Brescia, Italy., Cavalca F; Hematology Division and Bone Marrow Transplant, San Gerardo Hospital, ASST Monza, Monza, Italy., Bellosillo B; Hospital del Mar - IMIM, Barcelona, Spain., Benajiba L; Hospital Saint-Louis, Paris, France., Curto-Garcia N; Guy's and St. Thomas' NHS Foundation Trust, London, UK., Bellini M; ASST Papa Giovanni XXIII, Bergamo, Italy., Betti S; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico 'A. Gemelli' IRCCS, Rome, Italy., Harrison C; Guy's and St. Thomas' NHS Foundation Trust, London, UK., Rambaldi A; ASST Papa Giovanni XXIII, Bergamo, Italy.; Università degli Studi di Milano, Milano, Italy., Vannucchi AM; Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Feb 04; Vol. 11 (2), pp. 21. Date of Electronic Publication: 2021 Feb 04.